,,ii #aafth ,,congress #b;d ,session ,s4 #dedb ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,september #i1 #bjbj,mr4 ,tillis introduced the following bill2 which was read twice and referred to the ,committee on ,banking1 ,housing1 and ,urban ,affairs ,a ,,bill ,to prohibit distribution abroad of ,,covid-#ai vaccines developed with the support of ,federal funding until the domestic need for the vaccine has been met4 #a4 ,short title ,this ,act may be cited as the ,america ,first ,vaccine ,act4 #b4 ,,covid-#ai vaccine distribution 7a7 ,certification requirement 7#a7 ,in general ,notwithstanding any other provision of law1 subject to paragraph 7#b71 a manufacturer of a vaccine described in subsection 7b7 that is headquartered in the ,united ,states may not distribute such vaccine outside of the ,united ,states unless the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary71 in consultation with the ,commissioner of ,food and ,drugs1 certifies that domestic need for the vaccine already has been met4 7#b7 ,waiver ,the ,secretary may waive the certification requirement under paragraph 7#a7 with respect to a vaccine described in subsection 7b7 and permit the distribution of such vaccine outside of the ,united ,states1 if the ,secretary determines that such waiver and distribution is in the interest of the ,american public health4 7b7 ,vaccines described ,a vaccine described in this subsection is a ,,covid-#ai vaccine that-- 7#a7 is authorized under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#c7 or licensed under section #cea of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb72 and 7#b7 was developed with support of ,federal funding made available under the ,coronavirus ,preparedness and ,response ,supplemental ,appropriations ,act 7,public ,law #aaf-abc71 the ,families ,first ,coronavirus ,response ,act 7,public ,law #aaf-abg71 the ,coronavirus ,aid1 ,relief1 and ,economic ,security ,act 7,public ,law #aaf-acf71 or the ,paycheck ,protection ,program and ,health ,care ,enhancement ,act 7,public ,law #aaf-aci74 7c7 ,violations ,in the case of a manufacturer who violates subsection 7a71 such manufacturer shall be required to reimburse the ,federal ,government for all amounts received by the manufacturer in support of development of the vaccine1 plus interest in an amount determined by the ,secretary of the ,treasury4 7d7 ,rule of construction ,nothing in this ,act shall be construed to limit or otherwise restrict the ,secretary's authority to enter into bilateral or multilateral agreements with international manufacturers to procure vaccines described in subsection 7b7 for the people of the ,united ,states4